Division of Pediatric Infectious Diseases Archive — Page 3 of 10
-
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
May 10, 2022
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. -
March 30, 2022
Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.
“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction." -
March 7, 2022
Teen shares his battle with MIS-C following COVID-19 infection
Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection. -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 17, 2022
VUMC recognized for antimicrobial drug stewardship efforts
-
February 3, 2022
Study finds shorter treatment better for young children with outpatient pneumonia
A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.